回复:迷迷糊糊的疱疹系列研究----先从感叹开始
NanoBio and GSK Commence Phase 3 Studies of
Nanoemulsion-based OTC Treatment for Cold SoresANN ARBOR, Mich. (May 11, 2011) — NanoBio® Corporation today announced the initiation of two Phase 3 multicenter trials evaluating NB-001 as a topical treatment for cold sores, a step forward in their OTC licensing agreement with GlaxoSmithKline Consumer Healthcare (GSK CH).
In December 2009, GSK CH licensed exclusive rights in the United States and Canada to NB-001 for the OTC treatment of cold sores. GSK currently offers the market-leading cold sore treatment Abreva, the only OTC medicine approved by the Food & Drug Administration (FDA) to shorten cold sore healing time.
The two trials of NB-001 will be conducted in 1700 subjects at 72 clinical sites and will evaluate the effectiveness of NB-001 to reduce cold sore healing time.
“Based on the efficacy of NB-001 in Phase 2, we are very optimistic about these trials and the path to FDA approval,” said Mary Flack, MD, Vice President of Clinical Research, NanoBio. “Cold sores are painful and embarrassing for the roughly 20 percent of the US population that suffer from them. The initiation of these trials marks a significant step towards the commercialization of a new treatment offering for cold sores, as well as potential other new offerings to come from our nanoemulsion-based platform technology.”
一会上飞机了, 先把好消息送上。
以下的药是治疗疱疹, 缩短病程的, 已经进入临床三期。 药厂认为美国药监局获批上市应该没有问题。 2012年上市场。 大家又将多了一个选择。
迷糊
The trials are currently enrolling and are expected to conclude in 2012.
About NanoBio
NanoBio Corporation is a privately-held biopharmaceutical company focused on developing and commercializing dermatological products, anti-infective treatments and intranasal vaccines derived from its patented NanoStat® technology platform. The company’s lead product candidates are treatments for herpes labialis (licensed to GSK in the U.S. and Canada), onychomycosis, acne, cystic fibrosis and a broad platform of intranasal vaccines. The company’s headquarters and laboratory facilities are located in Ann Arbor, Michigan.